News
Eledon Shares Dip Despite Positive Phase 2 Results
November 7, 2025 • News
Companies mentioned:
Eledon Pharmaceuticals shares are trading lower despite announcing promising Phase 2 trial results for tegoprubart, likely due to investor caution over clinical development timelines and future regulatory discussions.